Passage Bio
PASG
PASG
66 hedge funds and large institutions have $863M invested in Passage Bio in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.15% more ownership
Funds ownership: 3.34% → 3.48% (+0.15%)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
Holders
66
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$44.7M | |
| 2 | +$21.5M | |
| 3 | +$14.1M | |
| 4 |
HCM
Highline Capital Management
New York
|
+$7.6M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.78M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$9.66M | |
| 3 | -$6.37M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.66M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.22M |